News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ProMetic Life Sciences Inc. (PFSCF.PK) : MacoPharma's P-CAPT'TM' Prion Capture Filter CE Marked


9/26/2006 10:43:46 AM

MONTREAL, CANADA AND LILLE, FRANCE -- (MARKET WIRE) -- September 26, 2006 -- Pathogen Removal and Diagnostic Technologies Inc. ("PRDT"), a joint venture between ProMetic Life Sciences Inc. (TSX: PLI) and the American Red Cross, along with PRDT's commercial and manufacturing partner, MacoPharma SA ("MacoPharma"), announced at the British Blood Transfusion Society Meeting, Bournemouth, 21-23rd September, 2006, that their prion capture filter, P-Captâ„¢, targeted initially at reduction of TSE pathogens from red blood cell concentrate, has received European Regulatory Approval (CE mark).

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES